4.7 Article

Colorimetric determination of sarcosine in urine samples of prostatic carcinoma by mimic enzyme palladium nanoparticles

期刊

ANALYTICA CHIMICA ACTA
卷 825, 期 -, 页码 63-68

出版社

ELSEVIER SCIENCE BV
DOI: 10.1016/j.aca.2014.03.040

关键词

Palladium nanoparticles; Mimic enzyme; Sarcosine; Prostatic carcinoma

资金

  1. National Natural Science Foundation of China [21105012, 21205015, 91022025, 21375017]
  2. National Science Foundation of Fujian Province [2011J01028]
  3. Fujian University Outstanding Youth Scientific Research [JA11105, JA10295]
  4. National Science Foundation for Distinguished Young Scholars of Fujian Province [2013J06003]
  5. Fujian Science and Technology [2013Y0045]
  6. Youth Foundation of Fujian Health Department [2010126]
  7. Foundation of Medical Innovation of Fujian Health Department [2011-CX-22]
  8. Foundation of Fuzhou Science and Technology Bureau [2012-S-148]

向作者/读者索取更多资源

The proposed palladium nanoparticles (Pd NPs), which with the catalytic activity similar to the horseradish peroxidase (HRP) mimic enzyme, can effectively catalyze the H2O2-mediated oxidation of 3,3 ',5,5 '-tetramethylbenzidine sulfate (TMB) accompanied with a color change from colorless to blue in solution. And as a result, the sensitive detection of sarcosine can be realized by the naked eye observation and ultraviolet spectrophotometry, using Pd NPs as catalyst and TMB as the substrate of the simulation enzyme catalytic reaction. Under the optimal condition, the catalytic system of Pd NPs mimic enzyme can be used for the detection of sarcosine. It has been found that the color change could be clearly observed with the naked eyes, and the absorbance intensity at 653 nm showed a fine linear fitting with the concentration of sarcosine in the range from 0.01 mu M to 50 mu M, and the detection limit (3 sigma/S) for sarcosine was calculated to be 5.0 nM. In order to evaluate the feasibility and reliability, the method was also used for analyzing concentrations of sarcosine in human urine samples from diagnosed prostate cancer patients and healthy donors. It is expected to provide a convenient and efficient method for indirect evaluation for the diagnosis of prostatic carcinoma (PCa). (C) 2014 Elsevier B. V. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据